Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier

Frank, 2001, Etiologic mechanisms in diabetic retinopathy, 1259 Vinores, 1997, Cellular mechanisms of blood-retinal barrier dysfunction in macular edema, Doc Ophthalmol, 97, 217, 10.1023/A:1002136712070 Dejana, 2001, Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration, Thromb Haemost, 86, 308, 10.1055/s-0037-1616228 Schneeberger, 2004, The tight junction: a multifunctional complex, Am J Physiol Cell Physiol, 286, C1213, 10.1152/ajpcell.00558.2003 Furuse, 1998, Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin, J Cell Biol, 141, 1539, 10.1083/jcb.141.7.1539 Das, 1999, Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes, Invest Ophthalmol Vis Sci, 40, 809 Das, 1998, Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor, Arch Ophthalmol, 117, 498, 10.1001/archopht.117.4.498 Noda, 2003, Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy, Invest Ophthalmol Vis Sci, 44, 2163, 10.1167/iovs.02-0662 Xu, 2001, Sensitive blood–retinal barrier breakdown quantitation using Evans blue, Invest Ophthalmol Vis Sci, 42, 789 Johnson, 2000, Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction, Anal Biochem, 278, 175, 10.1006/abio.1999.4461 Sasaki, 2003, Dynamic behavior of paired claudin strands within opposing plasma membranes, Proc Natl Acad Sci USA, 100, 3971, 10.1073/pnas.0630649100 Tavelin, 2003, A new principle for tight junction modulation based on occludin peptides, Mol Pharmacol, 64, 1530, 10.1124/mol.64.6.1530 El-Remessy, 2003, Experimental diabetes causes breakdown of the blood–retinal barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor, Am J Pathol, 162, 1995, 10.1016/S0002-9440(10)64332-5 Behzadian, 2003, VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor, FASEB J, 17, 752, 10.1096/fj.02-0484fje Lund, 1999, Functional overlap between two classes of matrix-degrading proteases in wound healing, EMBO J, 18, 4645, 10.1093/emboj/18.17.4645 Grant, 1998, Matrix metalloproteinase expression in human retinal microvascular cells, Diabetes, 47, 1311, 10.2337/diab.47.8.1311 Uemura, 2001, Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress, Circ Res, 88, 1291, 10.1161/hh1201.092042 Moore, 2003, The role of advanced glycation end products in retinal microvascular leukostasis, Invest Ophthalmol Vis Sci, 44, 4457, 10.1167/iovs.02-1063 Spitaler, 2002, Vascular targets of redox signaling in diabetes mellitus, Diabetologia, 45, 476, 10.1007/s00125-002-0782-0 Ellis, 2000, Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/WOR diabetic rat, Free Radic Biol Med, 28, 91, 10.1016/S0891-5849(99)00216-6 Chen, 1997, COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos, J Cell Biol, 138, 891, 10.1083/jcb.138.4.891 Balda, 1996, Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical–basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein, J Cell Biol, 134, 1031, 10.1083/jcb.134.4.1031 Wong, 1997, A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrrier, J Cell Biol, 136, 399, 10.1083/jcb.136.2.399 Yu, 1998, 72-kDa gelatinase (gelatinase A): structure, activation, regulation and substrate specificity, 85 Chiarelli, 2000, Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications, Diab Med, 17, 650, 10.1046/j.1464-5491.2000.00350.x Murata, 1996, The relation between expression of vascular endothelial growth factor and breakdown of the blood–retinal barrier in diabetic rat retinas, Lab Invest, 74, 819 Gilbert, 1998, Vascular endothelial growth factor and its receptors in control and diabetic rat eyes, Lab Invest, 78, 1017 Wang, 2001, VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly, Am J Physiol Heart Circ Physiol, 280, H434, 10.1152/ajpheart.2001.280.1.H434 Fisher, 2002, Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1, Microvasc Res, 63, 70, 10.1006/mvre.2001.2367 Antonetti, 1998, Vascular permeability in experimental diabetes is associated with reduced endothelial occluding content, Diabetes, 47, 1953, 10.2337/diabetes.47.12.1953 Antonetti, 1999, Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1, J Biol Chem, 274, 23463, 10.1074/jbc.274.33.23463 Antonetti, 1999, Molecular mechanisms of vascular permeability in diabetic retinopathy, Semin Ophthalmol, 14, 240, 10.3109/08820539909069543 Feng, 1999, VEGF-induced permeability increase is mediated by caveolae, Invest Ophthalmol Vis Sci, 40, 157